approval · primary record
EMAPALUMAB-LZSG
FDA · BLA · 2026-03-17
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-03-17 |
| Brand | GAMIFANT |
| Sponsor | NOVIMMUNE S.A. |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:50.411Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:EMAPALUMAB-LZSG:2026-03-17
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.